Breast areolar approach in endoscopic surgery versus open surgery for thyroid cancer in cT1N0 stage
10.3760/cma.j.issn.1674-6090.2020.01.005
- VernacularTitle:cT1N0甲状腺癌全乳晕入路腔镜手术与开放手术对比研究
- Author:
Ning ZHAO
1
;
Changsheng TENG
;
Xudong WANG
;
Daming YANG
;
Li WANG
;
Yuhang QI
;
Tiankuo GAO
;
Yumeng LIU
Author Information
1. 首都医科大学附属北京友谊医院普通外科，北京 100050
- From:
Chinese Journal of Endocrine Surgery
2020;14(1):18-22
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore whether endoscopic surgery can achieve the same effect on thyroid cancer as open surgery.Method:44 cases were selected to endoscopic thyroidectomy with breast areola approach, who were prepared to accept the surgical treatment of thyroid cancer with cT1N0 stages, female, ≤60 years old, no history of neck surgery and beauty desire. Fifty patients with the same conditions undergoing thyroid open surgery were as the control group.Results:Operative time of endoscopic group[ (170.0±28.0) min] was longer than that of the open operation group[ (90.0±21.0) min ( t=15.610, P=0.000) ]. There was no significant difference between the two groups in surgical complications ( P>0.05) . There was no statistical difference between the number of paratracheal and anterior tracheal lymph nodes of endoscopic group (6.0 ±4.2) and open surgery group (5.5 ±3.7) ( t=0.692, P>0.05) . There was no statistical difference between the number of anterior laryngeal lymph nodes of endoscopic group (0.7 ±1.1) and open surgery group (0.5 ±0.9) ( t=1.186, P>0.05) . Conclusion:The breast areola approach endoscopic thyroidectomy is safe and reliable in treatment of thyroid cancer, and the central cervical lymph node dissection is sufficient, which can be used as the choice of operation mode for thyroid cancer patients in cT1N0 stage.
